Publication | Closed Access
Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study
22
Citations
0
References
2017
Year
These findings suggest that a 0.5-mg/mL topical clonazepam solution is effective in the management of BMS. Future randomized clinical trials are warranted.